The prevalences of BRAF V600E and KRAS mutations in serrated and non-serrated adenomas and adenocarcinomas with high-level microsatellite instability (MSI-H) and microsatellite stability (MSS)/low-level microsatellite instability (MSI-L). The gene discussed is KRAS; the disease is adenocarcinoma.